Study of family connections in blood and lymph cancers
Genetic Epidemiology of Lymphoproliferative Disorders
This study looks at families with multiple members diagnosed with blood and lymph cancers to see if genetics and environmental factors play a role in their development.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT00626496 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the genetic and environmental factors that may contribute to the development of blood and lymph cancers, such as lymphoma and leukemia, which often show familial clustering. By examining families with multiple affected members, researchers aim to identify patterns and potential risk factors associated with these disorders. Participants will include families with at least two living blood relatives diagnosed with a lymphoproliferative disorder. The study will collect data on family history and environmental exposures to better understand the etiology of these cancers.
Who should consider this trial
Good fit: Ideal candidates for this study are families with at least two living blood relatives diagnosed with a lymphoproliferative disorder.
Not a fit: Patients without a family history of lymphoproliferative disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding of the risk factors for blood and lymph cancers, potentially guiding prevention and early detection strategies.
How similar studies have performed: Other studies have shown success in understanding familial patterns in cancer, suggesting that this approach could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.
Where this trial is running
Rochester, Minnesota
- Mayo Clinic — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Susan Slager, Ph.D. — Mayo Clinic
- Study coordinator: Catie Erding
- Email: Erding.Catherine@mayo.edu
- Phone: 1-855-899-0693
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.